Industry Sponsored Clinical Trials

Industry sponsored clinical trials
Standard

The Industrial Push

Clinical drug trials in todays times are majorly funded by the Pharmaceutical Industry thus increasing the dilemma and doubts in the minds of consumers regarding the commercialization of research. Due to the unprecedented control of the Pharmaceutical industry influencing the research to promote a drug is commonly observed. A conflict of interest is considered to exist when an author or authors company has a financial or personal relationship with organizations thus influencing their actions. Thus the impartiality of a research in todays time is threatened hence now its become imperative for investigators to disclose any form of financial conflict. However a large number of studies have reported an increase in disclosure of funding sources in research published thus promoting transparency. Manuscript guidelines hence have been revised to ensure the authors not only have an independent role in research but also are accountable for published result. At the same time these disclosure of conflict of interest have been known to be inconsistent and prone to deception. It is imperative not only for the investigators to know the best practices of disclosure but also for the medical writers, statisticians and other research staff.

Continue reading

Adaptive Design Clinical Trials

Adaptive Clinical Trials
Standard

Recently, there has been rise in the attrition rate in clinical research since drug development is an expensive and time-consuming process. Adaptive design clinical trial is a new concept, the regulatory agencies and industry has shown positive approach to this concept. It is a study that has opportunity for modification in the study hypothesis or design based on interim data collected from the participants of the study.

Continue reading